Correlation Between Novo Nordisk and UCB SA
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and UCB SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and UCB SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and UCB SA, you can compare the effects of market volatilities on Novo Nordisk and UCB SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of UCB SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and UCB SA.
Diversification Opportunities for Novo Nordisk and UCB SA
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Novo and UCB is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and UCB SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UCB SA and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with UCB SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UCB SA has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and UCB SA go up and down completely randomly.
Pair Corralation between Novo Nordisk and UCB SA
Assuming the 90 days horizon Novo Nordisk AS is expected to under-perform the UCB SA. In addition to that, Novo Nordisk is 1.7 times more volatile than UCB SA. It trades about -0.13 of its total potential returns per unit of risk. UCB SA is currently generating about -0.01 per unit of volatility. If you would invest 17,761 in UCB SA on August 28, 2024 and sell it today you would lose (361.00) from holding UCB SA or give up 2.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. UCB SA
Performance |
| Timeline |
| Novo Nordisk AS |
| UCB SA |
Novo Nordisk and UCB SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and UCB SA
The main advantage of trading using opposite Novo Nordisk and UCB SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, UCB SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UCB SA will offset losses from the drop in UCB SA's long position.The idea behind Novo Nordisk AS and UCB SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| UCB SA vs. Bolt Biotherapeutics | UCB SA vs. Cara Therapeutic | UCB SA vs. Arcus Biosciences | UCB SA vs. Senti Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |